- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 311/76 - Benzo [c] pyrans
Patent holdings for IPC class C07D 311/76
Total number of patents in this class: 150
10-year publication summary
|
12
|
12
|
17
|
10
|
5
|
7
|
11
|
14
|
8
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
10 |
| Autifony Therapeutics Limited | 51 |
7 |
| Sumitomo Pharma America, Inc. | 70 |
7 |
| PGI Drug Discovery LLC | 32 |
6 |
| CoreTerra Therapeutics, Inc. | 17 |
6 |
| Sunovion Pharmaceuticals Inc. | 244 |
5 |
| BASF SE | 21320 |
3 |
| Orion Corporation | 785 |
3 |
| Zhejiang Ausun Pharmaceutical Co., Ltd. | 45 |
3 |
| USA Elixiria Biotech Inc | 3 |
3 |
| International Business Machines Corporation | 62805 |
2 |
| Beijing Shenogen Pharma Group Ltd. | 20 |
2 |
| Biogen MA Inc. | 943 |
2 |
| BioMarin Pharmaceutical Inc. | 399 |
2 |
| The Hospital for Sick Children | 414 |
2 |
| The Jackson Laboratory | 376 |
2 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 177 |
2 |
| Invizyne Technologies, Inc. | 16 |
2 |
| Inventisbio LLC | 42 |
2 |
| Inventisbio Co., Ltd. | 84 |
2 |
| Other owners | 77 |